Briefings in Bioinformatics,
Journal Year:
2024,
Volume and Issue:
25(3)
Published: March 27, 2024
Ferroptosis
is
a
non-apoptotic,
iron-dependent
regulatory
form
of
cell
death
characterized
by
the
accumulation
intracellular
reactive
oxygen
species.
In
recent
years,
large
and
growing
body
literature
has
investigated
ferroptosis.
Since
ferroptosis
associated
with
various
physiological
activities
regulated
variety
cellular
metabolism
mitochondrial
activity,
been
closely
related
to
occurrence
development
many
diseases,
including
cancer,
aging,
neurodegenerative
ischemia-reperfusion
injury
other
pathological
death.
The
regulation
mainly
focuses
on
three
pathways:
system
Xc-/GPX4
axis,
lipid
peroxidation
iron
metabolism.
genes
involved
in
these
processes
were
divided
into
driver,
suppressor
marker.
Importantly,
small
molecules
or
drugs
that
mediate
expression
are
often
good
treatments
clinic.
Herein,
newly
developed
database,
named
'FERREG',
documented
(i)
providing
data
ferroptosis-related
diseases
occurrence,
progression
drug
response;
(ii)
explicitly
describing
molecular
mechanisms
underlying
each
regulation;
(iii)
fully
referencing
collected
cross-linking
them
available
databases.
Collectively,
FERREG
contains
51
targets,
718
regulators,
445
158
disease
responses.
can
be
accessed
at
https://idrblab.org/ferreg/.
Immunological Reviews,
Journal Year:
2023,
Volume and Issue:
321(1), P. 228 - 245
Published: Oct. 30, 2023
Summary
Ferroptosis
is
a
novel
form
of
programmed
cell
death
morphologically,
genetically,
and
biochemically
distinct
from
other
pathways
characterized
by
the
accumulation
iron‐dependent
lipid
peroxides
oxidative
damage.
It
now
understood
that
ferroptosis
plays
an
essential
role
in
various
biological
processes,
especially
metabolism
iron,
lipids,
amino
acids.
Gastric
cancer
(GC)
prevalent
malignant
tumor
worldwide
with
low
early
diagnosis
rates
high
metastasis
rates,
accounting
for
its
relatively
poor
prognosis.
Although
chemotherapy
commonly
used
to
treat
GC,
drug
resistance
often
leads
therapeutic
outcomes.
In
last
several
years,
extensive
research
on
has
highlighted
significant
potential
GC
therapy,
providing
promising
strategy
address
associated
standard
therapies.
this
review,
we
offer
summary
key
regulatory
factors
related
mechanisms
underlying
ferroptosis.
Various
inducers
inhibitors
specifically
targeting
are
uncovered.
Additionally,
explore
prospective
applications
outcomes
these
agents
field
emphasizing
their
capacity
improve
patient
population.
Cellular Signalling,
Journal Year:
2024,
Volume and Issue:
122, P. 111345 - 111345
Published: Aug. 10, 2024
In
tumors,
the
rapid
proliferation
of
cells
and
imperfect
blood
supply
system
lead
to
hypoxia,
which
can
regulate
adaptation
tumor
hypoxic
environment
through
hypoxia-inducible
factor-1α
(HIF-1α)
promote
development
in
multiple
ways.
Recent
studies
have
found
that
epithelial-mesenchymal
transition
(EMT)
ferroptosis
play
important
roles
progression
cells.
The
activation
HIF-1α
is
considered
a
key
factor
inducing
EMT
When
activated,
it
EMT-related
genes,
causing
gradually
lose
their
epithelial
characteristics
acquire
more
invasive
mesenchymal
traits.
occurrence
allows
better
adapt
changes
surrounding
tissue,
enhancing
migratory
capabilities,
thus
promoting
progression.
At
same
time,
also
plays
crucial
regulatory
role
environment,
may
affect
processes
such
as
iron
metabolism
oxidative
stress
responses,
This
article
briefly
reviews
dual
cells,
helping
gain
deeper
understanding
pathways
providing
new
perspective
for
pathogenesis
tumors.
regulation
become
an
strategy
future
therapy.
Small,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 3, 2024
Abstract
Amplifying
oxidative
stress
within
tumor
cells
can
effectively
inhibit
the
growth
and
metastasis
of
triple‐negative
breast
cancer
(TNBC).
Therefore,
development
innovative
nanomedicines
that
disrupt
redox
balance
represents
a
promising
yet
challenging
therapeutic
strategy
for
TNBC.
In
this
study,
an
amplifier,
denoted
as
PBCH,
comprising
PdAg
mesoporous
nanozyme
CaP
mineralized
layer,
loaded
with
GSH
inhibitor
L‐buthionine
sulfoximine
(BSO),
further
surface‐modified
hyaluronic
acid
target
CD44,
is
introduced.
acidic
microenvironment,
Ca
2+
initially
released,
thereby
leading
to
mitochondrial
dysfunction
eventually
triggering
apoptosis.
Additionally,
BSO
suppresses
synthesis
intracellular
reduced
amplifies
level
in
cells.
Furthermore,
be
activated
by
near‐infrared
light
induce
photothermal
photodynamic
effects,
causing
burst
ROS
simultaneously
promoting
cell
apoptosis
via
provoking
immunogenic
death.
The
high‐performance
effects
based
on
synergistic
effect
aforementioned
multiple
damage
ablation,
are
validated
TNBC
animal
models,
declaring
its
potential
safe
effective
anti‐tumor
agent.
proposed
approach
offers
new
perspectives
precise
efficient
treatment
Aging and Disease,
Journal Year:
2024,
Volume and Issue:
unknown, P. 0 - 0
Published: Jan. 1, 2024
Programmed
cell
death
is
pivotal
for
several
physiological
processes,
including
immune
defense.
Further,
it
has
been
implicated
in
the
pathogenesis
of
developmental
disorders
and
onset
numerous
diseases.
Multiple
modes
programmed
death,
apoptosis,
pyroptosis,
necroptosis,
ferroptosis,
have
identified,
each
with
their
own
unique
characteristics
biological
implications.
In
February
2023,
Liu
Xiaoguang
his
team
discovered
"disulfidptosis,"
a
novel
pathway
death.
Their
findings
demonstrated
that
disulfidptosis
triggered
glucose-starved
cells
exhibiting
high
expression
protein
called
SLC7A11.
Furthermore,
marked
by
drastic
imbalance
NADPH/NADP+
ratio
abnormal
accumulation
disulfides
like
cystine.
These
changes
ultimately
lead
to
destabilization
F-actin
network,
causing
Given
SLC7A11
key
feature
certain
cancers,
these
indicate
could
serve
as
basis
innovative
anti-cancer
therapies.
Hence,
this
review
delves
into
discovery
disulfidptosis,
its
underlying
molecular
mechanisms
metabolic
regulation,
prospective
applications
disease
treatment.
Frontiers in Oncology,
Journal Year:
2024,
Volume and Issue:
14
Published: March 7, 2024
Lung
cancer
is
a
highly
prevalent
malignant
tumor
worldwide,
with
high
incidence
and
death
rates.
Recently,
there
has
been
increasing
recognition
of
the
role
ferroptosis,
unique
cell
mechanism,
in
lung
cancer.
This
review
aims
to
summarize
current
research
progress
on
relationship
between
ferroptosis
It
also
provides
comprehensive
analysis
regulatory
processes
various
stages,
including
epigenetics,
transcription,
post-transcription,
translation,
post-translation.
Additionally,
explores
dual
nature
progression,
which
presents
interesting
therapeutic
possibilities.
On
one
hand,
can
promote
escape
immune
surveillance
reduce
efficacy
treatment
early
stages
tumors.
other
it
counter
drug
resistance,
enhance
radiosensitivity,
immunotherapy.
The
article
discusses
combination
strategies
based
mechanism
ferroptosis.
Overall,
this
offers
holistic
perspective
onset,
contribute
future
clinical
interventions
field.